Consultants

Dr Ndabezinhle Mazibuko

MBBS

Clinical Research Fellow in Clinical Neuroscience (Institute of Psychiatry, Psychology and Neuroscience – King’s College London)

Dr Ndabezinhle Mazibuko is Clinical Research Fellow in Clinical Neuroscience (Institute of Psychiatry, Psychology and Neuroscience – King’s College London) whose work includes clinical trial design, management and data analysis with respect to pharmacological and neuro-imaging studies in both the academic and industry sectors.

His academic role includes medical student tutoring and periodic lectures. Prior to that he was an Acute Stroke and Neurology Registrar at King’s College Hospital and has several years’ experience as a clinician in varied disciplines within the NHS in addition to clinical experience in Australia (where he trained) and also in Africa.

He has a keen interest in Public Health Medicine and now also assists The Health Services and Population Research Department at King’s College London with data analysis with a view to policy creation and implementation for Non Communicable Diseases.

Since October 2014 he has clinically reviewed patients through the Care Oncology Clinic, implementing the protocol for the clinic. The medication regime that the clinic uses has its foundation in metabolic treatment with which Dr Mazibuko has extensive clinical experience.

Dr R. Saso

MD MPhil PhD

Haemato-Oncologist/Transplant Physician

Dr Saso was born, educated and medically trained in Yugoslavia. He worked in different university hospitals as a junior doctor at home and abroad (USA, UK) and completed his postgraduate studies at the Immunology Research Centre, University of Belgrade.

Going forward, he worked on studies in the field of haematology, immunochemistry and neuro-immunology. His research focused on defining and staging lympho-proliferative diseases, as well as acute leukaemias, CML, AA/PNH and MDS and he completed his training in internal medicine, haematology/oncology at home and abroad.

He spent a year as a British Council Scholar at St Thomas’ Hospital and RPMS at Hammersmith Hospital. In addition to gaining clinical experience, he furthered his studies in internal medicine and haematology. He also undertook research on the role of different lymphokines and soluble factors in antigen presentation and T-lymphocyte proliferation. Results of the research were presented at the annual BSI Congress.

After obtaining his doctorate, he was promoted to Assistant Professor in Internal Medicine/Haematology in 1991 at the University of Saints Cyril & Methodius, Skopje.

In 1992, supported by the British Council, he returned to the UK and continued his work and professional development in haemato-oncology, initially at St George’s, and since then, at several other leading UK teaching hospitals and cancer centres.

Dr Saso’s long-term interest is in haemato-oncology and bone marrow transplantation. During the course of his career he has introduced new treatment modalities and diagnostic methods in haemato-oncology. He also helped to establish and run  the Anticoagulant Clinic at the Royal Brompton Hospital.  He has published many papers in peer-reviewed journals and presented his work at international conferences and meetings (ASH, BSH, EBMT etc).

 

Dr Samir Agrawal

MRCP FRCPath PhD

Barts Health NHS Trust and Barts Cancer Institute, Queen Mary University of London, London, UK

Samir Agrawal is a Senior Lecturer in Haematology at the Queen Mary University of London and a Consultant Haemato-Oncologist at St Bartholomew’s Hospitals and The Barts Health NHS Trust, London UK.

Dr Agrawal qualified at the University of Bristol, UK, trained at The Royal Marsden Cancer Hospital, London, UK, and was awarded his PhD in Tumour Immunology from the University of Paris, France. He is Director of the Stem Cell Laboratory of the Barts Health NHS Trust, and has an interest in diagnostic immunophenotyping. He was a winner of the NHS Innovator Award in 2006 for the introduction of new diagnostic tests for the diagnosis of human leukaemias.

Dr Agrawal’s clinical activities stretch across all areas of haematological cancers, ranging from intensive chemotherapy for acute leukaemia to outpatient non-intensive chemo-immunotherapy for lymphoid diseases, particularly chronic lymphocytic leukaemia (CLL) and other lymphoid malignancies. Dr Agrawal has designed, funded, and implemented studies on myelodysplastic syndromes, invasive aspergillosis and CLL. A former member of the UK CLL Trials Committee, he is a trustee for CLLSA (the patient-led support organisation for patients in the UK with CLL), as well as a NICE reviewer and the haemato-oncology representative on the UK IVIg initiative. He is a member of the European group (ECIL) for guidelines for infection management.

Dr Agrawal’s research activities are focussed on CLL biology and developing novel approaches to treating this incurable disease; and improving patient experience with the development of the “remote patient monitoring programme”, which allows specialist follow-up without requiring attendance at the hospital. His current activities in the field of invasive fungal disease include a diagnostic study of high-risk haematology patients looking at improved and earlier diagnosis. He is also working to develop clinical guidelines and integrated care pathways for managing infection in the high-risk haemato-oncology setting and to promote best practice and highlight new developments through educational meetings.

Dr Agrawal has published over 70 papers in journals such as the Journal of Clinical Investigation, Journal of Immunology, “_blank”>Blood, “_blank”>the British Medical Journal, and the “_blank”>Journal of Clinical Oncology.

Samir

Dr Padman Vamadevan

MA MBBS

Dr Padman Vamadevan completed a Natural Sciences degree at Queens’ College, Cambridge, and subsequently completed his medical degree on the fast-track programme at Guy’s, King’s and St Thomas’ School of Medicine in London. During his Academic Foundation training at Guy’s & St Thomas’ Hospitals, he worked at Quintiles Drug Research Unit as a Clinical Trials Physician, where he was involved in trial design and management, adverse event reporting, and trial data analysis.

Following this, he was appointed as an Academic Clinical Fellow in Clinical Pharmacology at St George’s Hospital. During this period, he published several peer-reviewed papers, and received a fellowship to speak about his research at the European Respiratory Society congress. He has also been a keen educator, both to medical students and allied health professionals, delivering a spectrum of teaching ranging from small group-based discussions to formal lectures.

Subsequently, he has taken up posts at the Macmillan Cancer Centre, Royal Marsden Hospital, and more recently, the Heart of Kent Hospice, which have afforded him significant relevant clinical experience. His familiarity with Biochemistry, Clinical Pharmacology, and Oncology are consistent with the academic lineages that underpin the metabolic treatments offered by the Care Oncology Clinic.